Declining incidence and improving survival of ocular and orbital lymphomas in the US between 1995 and 2018
Open Access
- 3 April 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-13
Abstract
This epidemiological study examined ocular and orbital lymphomas in the United States from 1995 to 2018, using data from the North American Association of Central Cancer Registries database of 87,543 patients with ocular and adnexal malignancies. We identified 17,878 patients (20.4%) with ocular and orbital lymphomas, with an age-standardized incidence rate (ASIR) of 2.6 persons per million (ppm). The incidence was the highest in the orbit (ASIR = 1.24), followed by the conjunctiva (ASIR = 0.57). Non-Hodgkin B-cell lymphoma was the most prevalent subtype (85.4%), particularly marginal-zone lymphoma (45.7%). Racial disparities were noted, with Asia–Pacific Islanders showing the highest incidence (orbit, 1.3 ppm). The incidence increased significantly from 1995 to 2003 (Average Percent Change, APC = 2.1%) but declined thereafter until 2018 (APC = − 0.7%). 5-year relative survival (RS) rates varied, with the highest rate for conjunctival lymphoma (100%) and the lowest for intraocular lymphoma (70.6%). Survival rates have generally improved, with an annual increase in the 5-year RS of 0.45%. This study highlights the changing epidemiological landscape, pointing to initial increases and subsequent decreases in incidence until 2003, with survival improvements likely due to advancements in treatment. These findings underscore the need for further research to investigate the root causes of these shifts and the declining incidence of ocular lymphoma.Keywords
Funding Information
- Charité - Universitätsmedizin Berlin
This publication has 71 references indexed in Scilit:
- Treatment strategies for patients with diffuse large B-cell lymphomaCancer Treatment Reviews, 2022
- Pediatric lymphoma patients in Malawi present with poor health‐related quality of life at diagnosis and improve throughout treatment and follow‐up across all Pediatric PROMIS‐25 domainsPediatric Blood & Cancer, 2021
- Tableau Software2020
- Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissueClinical and Experimental Medicine, 2017
- How generalizable are the SEER registries to the cancer populations of the USA?Cancer Causes & Control, 2016
- Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphomaCancer Causes & Control, 2012
- Malignant Lymphoma of the Lacrimal GlandArchives of Ophthalmology (1950), 2011
- Spectrum of orbital and ocular adnexal lesions: An analysis of 389 cases diagnosed by fine needle aspiration cytologyDiagnostic Cytopathology, 2011
- A Review of 244 Orbital Tumors in Japanese Patients During a 21-Year Period: Origins and LocationsJapanese Journal of Ophthalmology, 2005
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000